Aktana, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Aktana, Inc. - overview

Established

2008

Location

San Francisco, CA-California, US

Primary Industry

Software

About

Aktana, Inc. specializes in providing AI-driven solutions that enhance customer engagement strategies within the life sciences sector, focusing on healthcare provider interactions for improved omnichannel success. Founded in 2008 and headquartered in San Francisco, US, Aktana, Inc. develops AI solutions for the life sciences industry, enabling effective healthcare provider engagement.


The company has undergone strategic developments to enhance its core offerings and operates globally. Derek Choy is the founder, while the leadership team includes CEO David Ehrlich and John Vitalie. Aktana has successfully completed six deals, raising a total of USD 30 mn in Series D funding on September 4, 2020, reflecting a current company valuation of USD 135. 724 mn.


Aktana provides AI-powered solutions specifically designed for omnichannel success in the life sciences industry, with a focus on healthcare provider engagement. Its core product, the Aktana Platform, serves as an AI engine for customer engagement strategies, complemented by offerings such as Strategy Orchestration, Automated Intelligence, and Amplified Engagement. These solutions are tailored to various segments, including brand teams, medical affairs, and MedTech companies, maximizing engagement through personalized AI insights. Aktana serves over 350 brands across leading global life sciences firms, with deployments in North America, Europe, and Asia.


Aktana generates revenue through a B2B subscription model and managed services, allowing life sciences companies to effectively implement its AI solutions. Clients subscribe to various product suites tailored to their needs in healthcare provider engagement and data insights. While specific pricing details are not disclosed, the revenue model supports comprehensive solutions that enhance brand performance and medical education initiatives. Aktana's AI-driven recommendations and contextual intelligence capabilities are integral to their value proposition, ensuring competitiveness in an AI-centric market.


Aktana plans to leverage the USD 30 mn raised in Series D funding to enhance its product offerings and expand its market presence. The company is currently developing new solutions aimed at further optimizing healthcare provider engagement, with anticipated launches in the upcoming year. Additionally, Aktana targets expansion into emerging markets in Asia and Europe by 2023, aiming to extend its footprint in international life sciences markets.


Current Investors

Safeguard Scientifics, Starfish Ventures, Transformation Capital

Primary Industry

Software

Sub Industries

eMarketing/Digital Marketing, Pharmaceutical Research & Development, Sales & Marketing Software, Customer Relationship Management, Analytics & Performance Software

Website

www.aktana.com

Verticals

AdTech, Artificial Intelligence, Cloud Computing

Company Stage

Series D

Total Amount Raised

Subscriber access only

Aktana, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedTact.ai’s field engagement and conversational AI technology-
Series DCompletedAktana, Inc.-
Venture DebtCompletedAktana, Inc.-
Series CCompletedAktana, Inc.-
Series BCompletedAktana, Inc.-

Displaying 1 - 5 of 7

Aktana, Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Aktana, Inc. - key contacts

NamePositionStart DateEnd DateVcardBio 
Board MemberBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.